Dermbiont

Developer of microbial therapeutics designed to treat skin diseases

placeMelrose, Massachusetts, United States calendar_todayFounded 2015 groups36 employees language dermbiont.com

Registered entities

Innovation

7 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 296 times.

YearFilings
20201
20211
20222
20233
20245
20256

Investor mix

17 investors on record; lead investors include Zola Global, Toba Capital, Viking Global Investors, Double Point Ventures.

Investor typeCountShare
Venture capital1165%
Private equity16%
Angel & family office16%
Accelerator & incubator16%
Other / undisclosed318%
Coming soon